Eye Specialists of Indiana   Report issue

Academic/Hospital Phase 2
Founded: Indianapolis IN United States (1987)

Organization Overview

First Clinical Trial
2020
NCT04213885
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Eye Specialists of Indiana

Active Ingredients

Drugs in Phase 2 Trials (1)

riboflavin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratitis (Phase 2)

Keratoconus (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1